Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OMERACT systemic lupus erythematosus domain survey.
Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, Thumboo J, Aringer M, Mosca M, Bruce I, Parodis I, Kim A, Desai M, Enman Y, Shea B, Wallace DJ, Chaichian Y, Navarra S, Aranow C, Mackay M, Trotter K, Tayer-Shifman OE, Duarte-García A, Shan Tam L, Ugarte-Gil MF, Pons-Estel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Gladman DD, Arnaud L, Bultink IEM, Ruiz-Irastorza G, Inês LS, Appenzeller S, Dobrowolski C, Clarke AE, Kamen DL, Barraclough M, Tani C, Gómez-Puerta JA, Werth VP, Katz P, Nowrouzi-Kia B, Johnson SR, Drucker AM, Touma Z; OMERACT SLE Working Group. Nielsen W, et al. Among authors: gomez puerta ja. Semin Arthritis Rheum. 2024 Oct;68:152520. doi: 10.1016/j.semarthrit.2024.152520. Epub 2024 Jul 24. Semin Arthritis Rheum. 2024. PMID: 39106780
Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.
Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies). Espinosa G, et al. Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi: 10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10. Semin Arthritis Rheum. 2013. PMID: 22784445
Rheumatologic complications of CAR-T Cell therapy. Experience of a single center.
Gómez-Puerta JA, Monegal A, Ponce A, Peris P, Martínez-Cibrian N, Sarmiento-Monroy JC, Ortiz-Maldonado V, Triguero A, Fernández de Larrea C, Delgado J, García-Herrera A, Albero-González R, Bosch-Amate X, Español-Rego M, González A, Sanmartí R, Juan M. Gómez-Puerta JA, et al. Semin Arthritis Rheum. 2024 Dec 27;71:152610. doi: 10.1016/j.semarthrit.2024.152610. Online ahead of print. Semin Arthritis Rheum. 2024. PMID: 39754918
Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
Rua-Figueroa I, Altabás-González I, Mouriño C, Roberts K, Hernández-Martín A, Casafont-Solé I, Font-Urgelles J, Román-Ivorra JA, Navarro MR, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blazquez-Canamero MA, Fernandez-Cid CM, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo J, de Dios JR, Alvarez-Rodríguez B, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Pego-Reigosa JM. Rua-Figueroa I, et al. Rheumatology (Oxford). 2024 May 13:keae270. doi: 10.1093/rheumatology/keae270. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38741198
Clinical and structural damage outcomes in axial spondyloarthritis patients receiving NSAIDs or advanced therapies: a description of a real-life cohort.
Mocritcaia A, Chacur C, Adao Abe CD, Azuaga-Piñango AB, Frade-Sosa B, Sarmiento-Monroy JC, Alascio L, Gómez-Puerta JA, Sanmartí R, Cañete JD, Ramírez J. Mocritcaia A, et al. Among authors: gomez puerta ja. Front Med (Lausanne). 2024 Jun 20;11:1425449. doi: 10.3389/fmed.2024.1425449. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38966536 Free PMC article.
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I, Pego-Reigosa JM, Mouriño C, Jiménez N, Hernández-Martín A, Casafont-Solé I, Font Urguelles J, Román-Ivorra JA, de la Rubia Navarro M, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blázquez-Cañamero MÁ, Marras C, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo-Alén J, de Dios JR, Álvarez Rodríguez B, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Rúa-Figueroa IJ. Altabás-González I, et al. Rheumatology (Oxford). 2025 Jan 1;64(1):276-282. doi: 10.1093/rheumatology/kead696. Rheumatology (Oxford). 2025. PMID: 38490245 Free PMC article.
Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.
Gómara MJ, Sarmiento-Monroy JC, Castellanos-Moreira R, Gómez-Puerta JA, Sanmartí R, Haro I. Gómara MJ, et al. Among authors: gomez puerta ja. Int J Mol Sci. 2024 Oct 3;25(19):10654. doi: 10.3390/ijms251910654. Int J Mol Sci. 2024. PMID: 39408982 Free PMC article.
157 results